newsfilter
← Latest News
Business Wire·

MyMD Pharmaceuticals Announces New Data Demonstrating 8,000 Times Higher Potency of Novel Synthetic Supera-CBD over Plant-Derived CBD

Data indicates potential of drug candidate to deliver an extremely potent therapeutic benefit at a very low non-toxic dose New data will be presented at the 4th Annual International Cannabinoid-Derived Pharmaceuticals Summit in Boston MyMD Pharmac